Triglyceride glucose index superior to HOMA-IR for predicting type 2 diabetes: Study
Written By : Medha Baranwal
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2021-09-22 04:00 GMT | Update On 2021-09-22 04:41 GMT
Advertisement
Korea: A recent study in the journal Diabetes Research and Clinical Practice has shown the triglyceride-glucose (TyG) index to be superior to HOMA-IR for the prediction of type 2 diabetes. The findings imply that the TyG index may be a useful tool for the prevention and detection of T2D.
Previous studies have shown insulin resistance to be an independent risk factor for the development of type 2 diabetes. Jun-Hyuk Lee, Eulji University School of Medicine, Seoul, Republic of Korea, and colleagues aimed to compare the predictability of the triglyceride–glucose (TyG) index and the homeostatic model assessment of insulin resistance (HOMA-IR) for the prevalence and incidence of type 2 diabetes.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.